Gemcitabine/epirubicin/paclitaxel as neoadjuvant chemotherapy in locally advanced breast cancer: A phase II trial of the NSABP foundation research group

John T. Hamm, John W. Wilson, Priya Rastogi, Barry C. Lembersky, George C. Tseng, Young K. Song, Wanseop Kim, André Robidoux, Jane M. Raymond, Carl G. Kardinal, Ibrahim A. Shalaby, Rafat Ansari, Soonmyung Paik, Charles E. Geyer, Norman Wolmark

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'Gemcitabine/epirubicin/paclitaxel as neoadjuvant chemotherapy in locally advanced breast cancer: A phase II trial of the NSABP foundation research group'. Together they form a unique fingerprint.

Medicine & Life Sciences